Shares of Neuren Pharmaceuticals (ASX:NEU) rose almost 1% in early trading on Wednesday, while those of CSL (ASX:CSL) were marginally lower, following US President Donald Trump's remarks on tariffs on the pharmaceutical industry on Tuesday.
Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the US "very soon," adding that he will "give people about a year, year and a half," CNBC reported.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.